tiprankstipranks
Analysts Predict Up to ~450% Surge for These 2 ‘Strong Buy’ Penny Stocks
PremiumStock Analysis & IdeasAnalysts Predict Up to ~450% Surge for These 2 ‘Strong Buy’ Penny Stocks
1M ago
Foghorn Therapeutics Advances Drug Development in Oncology
Premium
Company Announcements
Foghorn Therapeutics Advances Drug Development in Oncology
1M ago
Foghorn Therapeutics initiated with a Buy at B. Riley
Premium
The Fly
Foghorn Therapeutics initiated with a Buy at B. Riley
1M ago
Foghorn Therapeutics price target lowered to $4 from $9 at Morgan Stanley
PremiumThe FlyFoghorn Therapeutics price target lowered to $4 from $9 at Morgan Stanley
3M ago
Foghorn Therapeutics price target lowered to $13 from $20 at H.C. Wainwright
Premium
The Fly
Foghorn Therapeutics price target lowered to $13 from $20 at H.C. Wainwright
3M ago
Foghorn Therapeutics price target lowered to $14 from $18 at Jefferies
Premium
The Fly
Foghorn Therapeutics price target lowered to $14 from $18 at Jefferies
3M ago
Foghorn Therapeutics Advances Oncology Pipeline with New Trials
PremiumCompany AnnouncementsFoghorn Therapeutics Advances Oncology Pipeline with New Trials
4M ago
Foghorn Therapeutics reports Q3 EPS (31c), consensus (44c)
Premium
The Fly
Foghorn Therapeutics reports Q3 EPS (31c), consensus (44c)
4M ago
FHTX Earnings this Week: How Will it Perform?
Premium
Pre-Earnings
FHTX Earnings this Week: How Will it Perform?
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100